|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.100 HKD | -0.90% |
|
+8.91% | +37.50% |
| 08-03 | Fusen Pharmaceutical Company Limited Selected in National Centralised Medicines Procurement in China | CI |
| 06-26 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| Market Cap | 700M 813M 104M 89.66M 83.73M 76.81M 144M 9.87B 147M 982M 386M 4.94B 389M 381M 16.35B | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 922M 1.07B 137M 118M 110M 101M 190M 13B 193M 1.29B 508M 6.51B 513M 502M 21.53B | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.90% | ||
| 1 week | +8.91% | ||
| Current month | +8.91% | ||
| 1 month | +10.00% | ||
| 3 months | -5.98% | ||
| 6 months | +48.65% | ||
| Current year | +37.50% |
| 1 week | 1.01 |  | 1.15 |
| 1 month | 1 | | 1.2 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.3 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 17/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 17/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 29/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 06/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 06/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 06/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/04/24 | Other | Chairman | 650,000 | 0.0867% | ||
| 18/04/24 | Other | Chairman | 240,000 | 0.0320% | ||
| 18/04/24 | Other | Chairman | 240,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | +8.91% | +238.46% | -24.66% | 104M | |
| -0.31% | -2.29% | +22.57% | +69.33% | 49.03B | |
| +4.40% | +14.46% | +62.66% | +133.25% | 42.33B | |
| -0.89% | -0.64% | -1.48% | +15.58% | 12.43B | |
| +0.56% | -1.12% | +19.02% | +70.02% | 11.68B | |
| +0.19% | +0.77% | +31.74% | +141.01% | 9.12B | |
| +1.99% | +4.41% | +17.56% | +34.79% | 7.15B | |
| +1.82% | -0.15% | +39.41% | -13.77% | 7.09B | |
| +0.40% | +2.02% | +12.85% | +176.30% | 6.76B | |
| +6.44% | +8.26% | -24.61% | +30.64% | 5.95B | |
| Average | +1.37% | +3.35% | +41.82% | +63.25% | 15.16B | |
| Weighted average by Cap. | +1.56% | +3.75% | +30.48% | +84.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 326M 379M 48.31M 41.79M 39.02M 35.8M 67.33M 4.6B 68.4M 458M 180M 2.3B 181M 177M 7.62B | 273M 318M 40.51M 35.04M 32.72M 30.02M 56.46M 3.86B 57.35M 384M 151M 1.93B 152M 149M 6.39B |
| Net income | -189M -219M -27.97M -24.2M -22.6M -20.73M -38.99M -2.66B -39.61M -265M -104M -1.33B -105M -103M -4.41B | -11.78M -13.7M -1.75M -1.51M -1.41M -1.29M -2.43M -166M -2.47M -16.55M -6.5M -83.3M -6.56M -6.41M -275M |
| Net Debt | 367M 427M 54.42M 47.07M 43.96M 40.32M 75.85M 5.18B 77.05M 516M 202M 2.6B 204M 200M 8.58B | 222M 258M 32.89M 28.45M 26.57M 24.38M 45.85M 3.13B 46.58M 312M 122M 1.57B 124M 121M 5.19B |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | HK$1.100 | -0.90% | 19,000 |
| 06/08/26 | HK$1.110 | 0.00% | 20,000 |
| 05/08/26 | HK$1.110 | +8.82% | 197,000 |
| 04/08/26 | HK$1.020 | +0.99% | 47,000 |
| 03/08/26 | HK$1.010 | 0.00% | 0 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
